These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6289586

  • 1. ACTH suppression after oral administration of cortisone in Addisonian and adrenalectomized patients.
    Aanderud S, Myking OL, Bassøe HH.
    Acta Endocrinol (Copenh); 1982 Aug; 100(4):588-94. PubMed ID: 6289586
    [Abstract] [Full Text] [Related]

  • 2. Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement.
    Feek CM, Ratcliffe JG, Seth J, Gray CE, Toft AD, Irvine WJ.
    Clin Endocrinol (Oxf); 1981 May; 14(5):451-8. PubMed ID: 6273020
    [Abstract] [Full Text] [Related]

  • 3. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA, Livesey JH, Florkowski C, Or HK, Donald RA, Espiner EA.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [Abstract] [Full Text] [Related]

  • 4. The dose-response relationship of ACTH and cortisol in Cushing's disease.
    Wolfsen AR, Odell WD.
    Clin Endocrinol (Oxf); 1980 Jun; 12(6):557-68. PubMed ID: 6249521
    [Abstract] [Full Text] [Related]

  • 5. The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.
    Reincke M, Allolio B, Kaulen D, Jaursch-Hancke C, Winkelmann W.
    Klin Wochenschr; 1988 Aug 01; 66(15):686-9. PubMed ID: 2845188
    [Abstract] [Full Text] [Related]

  • 6. Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: assessment with ACTH profiles.
    Ekman B, Blomgren J, Andersson PO, Carlsson M, Arnqvist HJ.
    Horm Metab Res; 2010 Dec 01; 42(13):961-6. PubMed ID: 20925018
    [Abstract] [Full Text] [Related]

  • 7. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
    Ambrosi B, Bochicchio D, Fadin C, Colombo P, Faglia G.
    J Endocrinol Invest; 1990 Mar 01; 13(3):257-61. PubMed ID: 1973178
    [Abstract] [Full Text] [Related]

  • 8. Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.
    Loli P, Berselli ME, Frascatani F, Muratori F, Tagliaferri M.
    J Endocrinol Invest; 1984 Apr 01; 7(2):93-6. PubMed ID: 6327800
    [Abstract] [Full Text] [Related]

  • 9. Steroid replacement in Addison's disease and in subjects adrenalectomized for Cushing's disease: comparison of various glucocorticoids.
    Khalid BA, Burke CW, Hurley DM, Funder JW, Stockigt JR.
    J Clin Endocrinol Metab; 1982 Sep 01; 55(3):551-9. PubMed ID: 6284785
    [No Abstract] [Full Text] [Related]

  • 10. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME, Orth DN, Halmi NS, Zielinski AC, Davis DR, Chavez FT, Drucker WD.
    Endocrinology; 1986 Aug 01; 119(2):720-30. PubMed ID: 3015556
    [Abstract] [Full Text] [Related]

  • 11. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B, Winkelmann W, Hipp FX, Kaulen D, Mies R.
    J Clin Endocrinol Metab; 1982 Jul 01; 55(1):1-7. PubMed ID: 6281297
    [Abstract] [Full Text] [Related]

  • 12. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT, Luria M.
    J Clin Endocrinol Metab; 1977 Feb 01; 44(2):361-8. PubMed ID: 190254
    [Abstract] [Full Text] [Related]

  • 13. Positive rate-sensitive corticosteroid feedback mechanism of ACTH secretion in Cushing's disease.
    Fehm HL, Voigt KH, Kummer G, Pfeiffer EF.
    J Clin Invest; 1979 Jul 01; 64(1):102-8. PubMed ID: 221540
    [Abstract] [Full Text] [Related]

  • 14. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M, Shibasaki T, Shizume K, Kiyosawa Y, Odagiri E, Suda T, Yamaguchi H, Tsushima T, Demura H, Maeda T.
    J Clin Endocrinol Metab; 1983 Nov 01; 57(5):963-8. PubMed ID: 6311867
    [Abstract] [Full Text] [Related]

  • 15. A correlative study between cortisol and ACTH in Cushing's disease following bilateral adrenalectomy and in Nelson's syndrome.
    Kasperlik-Załuska A, Niegowska E, Migdalska B, Jeske W, Zieliński M.
    Endokrynol Pol; 1992 Nov 01; 43(3):314-21. PubMed ID: 1345571
    [Abstract] [Full Text] [Related]

  • 16. Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease.
    Arvat E, Ramunni J, Maccagno B, Giordano R, Broglio F, Deghenghi R, Boscaro M, Ghigo E.
    Neuroendocrinology; 1999 Sep 01; 70(3):200-6. PubMed ID: 10516483
    [Abstract] [Full Text] [Related]

  • 17. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH, Schulte HM, Chrousos GP, Gold PW, Benker G, Peterson RE, Cutler GB, Loriaux DL.
    J Clin Endocrinol Metab; 1986 May 01; 62(5):1020-6. PubMed ID: 3007552
    [Abstract] [Full Text] [Related]

  • 18. GH-releasing peptide (GHRP-6)-induced ACTH release in patients with addison's disease: effect of glucocorticoid withdrawal.
    Martins MR, Pinto AC, Brunner E, Silva MR, Lengyel AM.
    J Endocrinol Invest; 2003 Feb 01; 26(2):143-7. PubMed ID: 12739742
    [Abstract] [Full Text] [Related]

  • 19. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec 01; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 20. The effect of low-dose naloxone infusion on plasma ACTH and LH in patients with Cushing's and Addison's diseases.
    Moreira AC, Foss MC, Iazigi N, Verissimo JM.
    Horm Metab Res; 1988 Apr 01; 20(4):230-4. PubMed ID: 2840381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.